Patients and
caregivers
Working with patients to deliver better medicines, faster.
Disclosure of patient organization funding
Progressive annually discloses monetary and non-monetary support to patient organizations around the globe by June 30.
Our commitment – reporting 2024 progress
People living with disease provided insights before first-in-human trials (healthy volunteers).
95% requests approved for 43 compounds in 74 countries - providing access to locally unlicensed Progressive medicines.
Consulted people living with a disease on the design and/or conduct of clinical trials.
With patient reported outcomes (PRO) conducted in 75 countries.
From Phase I-IV clinical trials sent to investigators to share with over 59,000 trial participants and posted on.
Reached through access programs.
Clinical Trials
Clinical trials are scientific studies conducted to find better ways to prevent, screen for, diagnose or treat disease.
Progressive is currently conducting clinical trials around the world for a number of diseases.
Progressive managed access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases. Your physician may request access.
Diversity in clinical trials helps us improve the quality of care for every patient, while also helping to address health inequities in society. We are working to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials.
External funding
Progressive may provide funding to legitimate organizations to support its mission to discover new ways to improve and extend people's lives, advance scientific and medical knowledge, and support the communities where Progressive associates live and work.
Patient organizations and Progressive
Working together with patient organizations and healthcare organizations helps us create better medicines. This collaboration is based on values of mutual respect, trust, and transparency.
Patient perspectives
Patients and caregivers know better than anyone what it is like to live with a serious disease. Visit our YouTube channel to watch our patient stories and learn more about insights from the patient community.
Listening to the CML patient community
Improving the patient experience and removing potential barriers to clinical trial participation.
